Sleep disturbances and dementia

Psychogeriatrics

Volumn 15, Issue 1, 2015, Pages 65-74

  Cipriani, Gabriele ^a   Lucetti, Claudio ^a   Danti, Sabrina ^a   Nuti, Angelo ^a  

^a Versilia Hospital   (Italy)

Author keywords

Alzheimer's disease; Dementia; Dementia with Lewy bodies; Frontotemporal dementia; Sleep disorders

Indexed keywords

ATOMOXETINE; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; GALANTAMINE; MELATONIN; NEUROLEPTIC AGENT; RAMELTEON; RIVASTIGMINE; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT;

ALZHEIMER DISEASE; AROUSAL; BEHAVIOR THERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COMORBIDITY; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; INSOMNIA; LEWY BODY; MENTAL DISEASE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; SLEEP PATTERN; AGED; DISEASE COURSE; PSYCHOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP WAKE DISORDERS;

AGED; ALZHEIMER DISEASE; COMORBIDITY; DEMENTIA; DISEASE PROGRESSION; HUMANS; PSYCHOPATHOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP WAKE DISORDERS;

EID: 84924751718     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12069     Document Type: Review

References (116)

1. Schroeder AM, Colwell CS. How to fix a broken clock. Trends Pharmacol Sci 2013; 34: 605-619.
2. Ohayon MM, Carskadon MA, Guilleminault C etal. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004; 27: 1255-1273.
3. Vitiello MV. Sleep disorders and aging: understanding the causes. J Gerontol A Biol Sci Med Sci 1997; 52: M189-M191.
4. Foley DJ, Monjan AA, Brown SL etal. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995; 18: 425-432.
5. Bliwise D. Sleep and circadian rhythm disorders in aging and dementia. In: Turek FW, Zee PC, eds. Regulation of Sleep and Circadian Rhythms. New York: Marcel Decker, Inc, 1999; 487-525.
6. Potvin O, Lorrain D, Forget H etal. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35: 491-499.
7. Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 2013; 36: 1027-1032.
8. Yaffe K, Laffan AM, Harrison SL etal. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306: 613-619.
9. Guarnieri B, Adorni F, Musicco M etal. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 2012; 33: 50-58.
10. McCurry SM, Logsdon RG, Teri L etal. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J Geriatr Psychiatry Neurol 1999; 12: 53-59.
11. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2001; 15: 777-796.
12. Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly. J Sleep Res 2005; 14: 177-185.
13. Sinforiani E, Terzaghi M, Pasotti C. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients. Neurol Sci 2007; 28: 96-99.
14. Moe KE, Vitiello MV, Larsen LH etal. Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 1995; 4: 15-20.
15. Christos GA. Is Alzheimer's disease related to a deficit or malfunction of rapid eye movement (REM) sleep? Med Hypotheses 1993; 41: 435-439.
16. Bombois S, Derambure P, Pasquier F, Monaca C. Sleep disorders in aging and dementia. J Nutr Health Aging 2010; 14: 212-217.
17. Nilsson PM, Nilsson JA, Hedblad B etal. Sleep disturbance in association with elevated pulse rate for prediction of mortality-consequences of mental strain? J Intern Med 2001; 250: 521-529.
18. Stone KL, Ensrud KE, Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med 2008; 9 (Suppl 1): S18-S22.
19. Kang JE, Lim MM, Bateman RJ etal. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326: 1005-1007.
20. Donaldson C, Tarrier N, Burns A. Determinants of carer stress in Alzheimer's disease. Int J Geriatr Psychiatry 1998; 13: 248-256.
21. Ballard CG, Eastwood C, Gahir M etal. A follow up study of depression in the carers of dementia sufferers. BMJ 1996; 312: 947.
22. Bianchetti A, Scuratti A, Zanetti O etal. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 1995; 6: 108-112.
23. Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991; 4: 204-221.
24. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol 2003; 38: 199-206.
25. van Someren EJ, Hagebeuk EE, Lijzenga C etal. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 1996; 40: 259-270.
26. Wilson RS, McCann JJ, Aggarwal NT etal. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease. Am J Psychiatry 2007; 164: 910-915.
27. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 1999; 282: 2215-2219.
28. Camargos EF, Pandolfi MB, Freitas MP etal. Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study. Arq Neuropsiquiatr 2011; 69: 44-49.
29. Ancoli-Israel S, Ayalon L. Diagnosis and treatment of sleep disorders in older adults. Am J Geriatr Psychiatry 2006; 14: 95-103.
30. Campbell SS. Duration and placement of sleep in a 'disentrained' environment. Psychophysiology 1984; 21: 106-113.
31. Yesavage JA, Friedman L, Ancoli-Israel S etal. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol 2003; 16: 131-139.
32. Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep 2009; 11: 20-26.
33. Buijs RM, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2001; 2: 521-526.
34. Mirmiran M, Swaab DF, Kok JH etal. Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res 1992; 93: 151-162.
35. Izak S. Basic anatomy and physiology of sleep. Am J Electroneurodiagnostic Technol 2006; 46: 18-38.
36. Ohashi Y, Okamoto N, Uchida K etal. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol Psychiatry 1999; 451: 1646-1652.
37. Mishima K, Tozawa T, Satoh K etal. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry 1999; 45: 417-421.
38. Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med 2007; 8: 623-636.
39. Craig D, Hart DJ, Passmore AP. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006; 29: 1003-1007.
40. Yesavage JA, Friedman L, Kraemer H etal. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol 2004; 17: 20-24.
41. Boeve BF, Silber MH, Ferman TJ etal. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16: 622-630.
42. Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000; 15: 1028-1033.
43. Harper DG, Stopa EG, McKee AC etal. Differential circadian rhythm disturbances in men with Alzheimer's disease and frontotemporal degeneration. Arch Gen Psychiatry 2001; 58: 353-360.
44. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985; 342: 37-44.
45. Pat-Horenczyk R, Klauber MR, Shochat T etal. Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging 1998; 10: 308-315.
46. Meguro K, Ueda M, Kobayashi I etal. Sleep disturbance in elderly patients with cognitive impairment, decreased daily activity and periventricular white matter lesions. Sleep 1995; 18: 109-114.
47. Bliwise DL, Carroll JS, Dement WC. Predictors of observed sleep/wakefulness in residents in long term care. J Gerontol 1990; 45: M126-130.
48. Boeve BF, Silber MH, Saper CB etal. Pathophysiology of REM sleep behavior disorder and relevance to neurodegenerative disease. Brain 2007; 130: 2770-2788.
49. Braak H, Del Tredici K, Rub U etal. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
50. Boddy F, Rowan EN, Lett D etal. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2007; 22: 529-535.
51. Ferman TJ, Smith GE, Boeve BF etal. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004; 62: 181-187.
52. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004; 17: 146-157.
53. Postuma RB, Gagnon JF, Vendette M etal. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72: 1296-1300.
54. Postuma RB, Gagnon JF, Montplaisir JY etal. REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis 2012; 46: 553-558.
55. Friedman JH, Millman RP. Sleep disturbances and Parkinson's disease. CNS Spectr 2008; 13 (3 Suppl 4): 12-17.
56. Marion MH, Qurashi M, Marshall G etal. Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? J Neurol 2008; 255: 192-196.
57. Lo Coco D, Cupidi C, Mattaliano A etal. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci 2012; 33: 371-373.
58. Anderson KN, Hatfield C, Kipps C etal. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol 2009; 16: 317-323.
59. Arnulf I, Nielsen J, Lohmann E etal. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 2008; 65: 482-488.
60. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry 2005; 76: 1337-1341.
61. Aharon-Peretz J, Masiah A, Pillar T etal. Sleep-wake cycles in multi-infarct dementia and dementia of the Alzheimer type. Neurology 1991; 41: 1616-1619.
62. Cheng CY, Tsai CF, Wang SJ etal. Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia. J Geriatr Psychiatry Neurol 2013; 26: 158-1564.
63. Lugaresi E, Medori R, Montagna P etal. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997-1003.
64. Cortelli P, Gambetti P, Montagna P etal. Fatal familial insomnia: clinical features and molecular genetics. J Sleep Res 1999; 8 (Suppl 1): 23-29.
65. Sforza E, Montagna P, Tinuper P etal. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr Clin Neurophysiol 1995; 94: 398-405.
66. Gambetti P, Parchi P, Petersen RB etal. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 1995; 5: 43-51.
67. Foley DJ, Monjan AA, Izmirlian G, Hays JC, Blazer DG. Incidence and remission of insomnia among elderly adults in a biracial cohort. Sleep 1999; 22 (Suppl 2): S373-S378.
68. Arbus C, Gardette V, Cantet CE etal. Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study. J Nutr Health Aging 2011; 15: 609-617.
69. Mulin E, Zeitzer JM, Friedman L etal. Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study. J Alzheimers Dis 2011; 25: 85-91.
70. McCurry SM, Gibbons LE, Logsdon RG, Teri L. Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease. J Gerontol Nurs 2004; 30: 12-20.
71. Moran M, Lynch CA, Walsh C etal. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 2005; 6: 347-352.
72. Ancoli-Israel S, Klauber MR, Gillin JC. Sleep in non-institutionalized Alzheimer's disease patients. Aging (Milano) 1994; 6: 451-458.
73. Rebok GW, Rovner BW, Folstein MF. Sleep disturbance in Alzheimer's disease: relationship to behavioural problems. Aging 1991; 3: 193-196.
74. García-Alberca JM, Lara JP, Cruz B etal. Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment. J Nerv Ment Dis 2013; 201: 251-257.
75. Shin HY, Han HJ, Shin DJ etal. Sleep problems associated with behavioral and psychological symptoms as well as cognitive functions in Alzheimer's disease. J Clin Neurol 2014; 10: 203-209.
76. Jensen E, Dehlin O, Hagberg B etal. Insomnia in an 80-year-old population: relationship to medical, psychological and social factors. J Sleep Res 1998; 7: 183-189.
77. Irwin M, McClintick J, Costlow C etal. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 1996; 10: 643-653.
78. Tractenberg RE, Singer CM, Cummings JL etal. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. J Sleep Res 2003; 12: 331-3317.
79. Cummings JL, Mega M, Gray K etal. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
80. Morin CM, Bootzin RR, Buysse DJ etal. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006; 29: 1398-1414.
81. Neef D, Larson D. Sleep and quality of life in clinical medicine. In: Verster JC, Pandi-Perumal SR, Sreiner DL, eds. Sleep and Quality of Life in Clinical Medicine. Totowa, NJ: Humana Press, 2008; 158-160.
82. Chesson A, Littner M, Davila D etal. Practice parameters for the use of light therapy in the treatment of sleep disorders. Sleep 1999; 22: 641-660.
83. Morgenthaler TI, Lee-Chiong T, Alessi CA etal. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007; 30: 1445-1459.
84. Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev 1995; 19: 553-571.
85. Dowling GA, Hubbard EM, Mastick J etal. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr 2005; 17: 221-236.
86. Dowling GA, Mastick J, Hubbard EM, Luxenberg JS, Burr RL. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. Int J Geriatr Psychiatry 2005; 20: 738-743.
87. Colenda CC, Cohen W, McCall WV etal. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord 1997; 11: 175-178.
88. Spence DW, Kayumov L, Chen A etal. Acupuncture increases nocturnal melatonin secretion and reduces insomnia and anxiety: a preliminary report. J Neuropsychiatry Clin Neurosci 2004; 16: 19-28.
89. Brown CA, Berry R, Tan MC etal. A critique of the evidence base for non-pharmacological sleep interventions for persons with dementia. Dementia 2013; 12: 210-2137.
90. Skene DJ, Vivien-Roels B, Sparks DL etal. Daily variation in the concentration of melatonin and 5- methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res 1990; 528: 170-174.
91. Uchida K, Okamoto N, Ohara K etal. Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res 1996; 717: 154-159.
92. Mahlberg R, Walther S, Kalus P etal. Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol Aging 2008; 29: 203-209.
93. Srinivasan V, Pandi-Perumal SR, Cardinali DP etal. Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav Brain Funct 2006; 2: 15.
94. Singer C, Jackson J, Moffit M etal. Physiologic melatonin administration and sleep-wake cycle in Alzheimer's disease: a pilot study. Sleep Res 1994; 23: 84.
95. Singer C, Moffit M, Colling E etal. Low dose melatonin administration and nocturnal activity levels in patients with Alzheimer's disease. Sleep Res 1997; 26: 752.
96. Cardinali DP, Furio AM, Brusco L. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr Neuropharmacol 2010; 8: 218-227.
97. Borja NL, Daniel KL. Ramelteon for the treatment of insomnia. Clin Ther 2006; 28: 1540-1555.
98. Roth T, Seiden D, Sainati S etal. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 2006; 7: 312-318.
99. Jennum P, Santamaria J, Members of the Task Force. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke). Eur J Neurol 2007; 14: 1189-1200.
100. Lovestone S, Gauthier S. Sleep disturbances in Alzheimer's disease. In: Dunitz M, ed. Management of Dementia. London: Lundbeck Institute, 2001; 29-30.
101. Folks DG, Burke WJ. Psychotherapeutic agents in older adults. Sedative hypnotics and sleep. Clin Geriatr Med 1998; 14: 67-86.
102. Wirz-Justice A, Werth E, Savaskan E etal. Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14: 212-215.
103. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 2005; 66: 469-476.
104. James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 2004; 65: 752-755.
105. de Jesus Cabeza R, Zoltoski RK, Gillin JC. Biochemical pharmacology of sleep. In: Chokroverty S, ed. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Boston, MA: Butterworth-Heinemann, 1994; 37-56.
106. Burns A, Rossor M, Hecker J etal. The effects of donepezil in Alzheimer's disease-results from a multinational trial. Dement Geriatr Cogn Disord 1999; 10: 237-244.
107. Rogers SL, Doody RS, Mohs RC etal. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Arch Intern Med 1998; 158: 1021-1031.
108. Ross JS, Shua-Haim JR. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. J Am Geriatr Soc 1998; 46: 119-120.
109. Corey-Bloom J, Anand R, Veach J. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychiatry 1998; 1: 55-65.
110. Raskind MA, Peskind ER, Wessel T etal. Galantamine USA-1 Study Group. Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology 2000; 54: 2261-2268.
111. Rosler M, Anand R, Cicin-Sain A etal. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomized controlled trial. BMJ 1999; 318: 633-638.
112. Tariot PN, Solomon PR, Morris JC etal. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 2000; 54: 2269-2276.
113. Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomized controlled trial. Galantamine International-1 Study Group. BMJ 2000; 321: 1445-1449.
114. Stahl SM, Markowitz JS, Papadopoulos G etal. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Curr Med Res Opin 2004; 20: 517-524.
115. Weintraub D, Mavandadi S, Mamikonyan E etal. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75: 448-455.
116. Litvinenko IV, Krasakov IV, Tikhomirova OV. Sleep disorders in patients with dementia in Parkinson's disease. Neurosci Behav Physiol 2013; 43: 221-226.